FDA Expands Sampling and Testing of Marketed Medicines
Through its Enhanced Approach for Sampling and Testing (EAST) program, the US Food and Drug Administration combines rapid analytical techniques with established testing methods. The agency aims to test more medicines from US and overseas manufacturers, detect potential quality issues earlier, and use the findings to inform risk-based inspection planning.
The FDA purchases samples from retail pharmacies and wholesale distributors. Testing focuses on the identity and amount of the active ingredient and on potential impurities. When further evaluation is needed, the FDA uses validated methods for confirmatory testing, such as those described in the United States Pharmacopeia (USP).
Source:
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.